Abstract
Cardiac arrhythmias are encountered frequently in primary care settings. Because of their diverse nature and the volume of information available, an extensive discussion of this topic is beyond the scope of this chapter. The discussion here focuses on the most important aspects of the outpatient management of common cardiac arrhythmias. The goal of this chapter is to present a practical, step-by-step approach to their diagnosis and management. In general, the discussion applies only to adult patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baerman JM, Morady F, DiCarlo LA, de Buitleir M, Arbor A. Differentiation of ventricular tachycardia from supraventricular tachycardia with aberration: value of the clinical history. Ann Emerg Med 1987; 16(1): 40/63–43/66.
Grauer K, Cavallaro D. ACLS: a comprehensive review. Vol. II. 3rd ed. St. Louis: Mosby Year Book, 1993.
Roberge R, Anderson E, MacMath T, Rudoff J, Luten R. Termination of paroxysmal supraventricular tachycardia by digital rectal massage. AnnEmerg Med 1987;16:1291/139–1293/141.
Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1621–9.
Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990;322:863–8.
Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: a randomized, double-blinded trial. Ann Intern Med 1987;106:503–6.
Falk RH, Leavitt JI. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med 1991;114:573–5.
Dunn M, Alexander J, de Silva R, Hildner F. Antithrombotic therapy in atrial fibrillation. Chest 1986;89:865–745.
Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 1990;82:1106–16.
Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973–7.
Grauer K. Anticoagulation in atrial fibrillation. Am Fam Physician 1992;45:2494–5.
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation: the Boston Area Anticoagulation Trial for Atrial Fibrillation investigators. N Engl J Med 1990;323:1505–11.
Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation—risk marker for stroke. N Engl J Med 1990;323:1556–8.
Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985;312:193–7.
Morganroth J. Premature ventricular complexes; diagnosis and indications for therapy. JAMA 1984;252:673–6.
Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986;314:271–5.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Increased mortality due to encainide or flecainide in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406–12.
CAST II Investigators. Effect of the antiarrhythmic agent moriciz-ine on survival after myocardial infarction. N Engl J Med 1992;327:227–33.
Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias: a meta-analysis. Circulation 1991;84:1977–83.
Ruskin JN, McGovern B, Garan H, DiMarco JP, Kelly E. Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med 1983;309:1302–6.
Grauer K, Leytern B. A systematic approach to Holter monitor interpretation. Am Fam Physician 1992;45:1641–8.
Grauer K, Gums J. Ventricular arrhythmias. Part II. Special concerns in evaluation. J Am Board Fam Pract 1988;1:201–6.
Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 1991;68:1025–31.
Balady GJ, Cadigan JB, Ryan TJ. Electrocardiogram of the athlete: an analysis of 289 professional football players. Am J Cardiol 1984;53:1339–43.
Brodsky M, Wu D, Denes P, et al. Arrhythmias documented by 24-hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977;39:390.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hatch, R.L., Grauer, K., Gums, J.G. (1994). Cardiac Arrhythmias. In: Taylor, R.B. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4005-9_79
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4005-9_79
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-4007-3
Online ISBN: 978-1-4757-4005-9
eBook Packages: Springer Book Archive